You are here: Industry Insights > Alvotech

News List

Alvotech and Oaktree enter merger deal to form biopharma company Pharmaceutical-Technology
December 09, 2021
Alvotech has signed a definitive merger agreement with special purpose acquisition company Oaktree Acquisition Corp II to form a publicly traded international biopharmaceutical company.
Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData expresspharma
March 22, 2021
Australia continues to focus on reducing healthcare expenditure and encouraging the use of biosimilars over their reference product.
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and New Zealand expresspharma
March 02, 2021
Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.
Alvotech and DKSH Extend Biosimilar Partnership in Asia contractpharma
September 27, 2020
Initial pipeline contains biosimilar candidates addressing multiple therapeutic areas.
Teva enters biosimilar commercialisation partnership with Alvotech pharmaceutical-technology
August 06, 2020
Israel-based Teva Pharmaceutical has formed an exclusive strategic collaboration with Alvotech to commercialise five biosimilar candidates in the US.
Alvotech, DKSH Partner to Bring Biosimilar to Asia contractpharma
March 27, 2020
Alvotech and DKSH have entered into an exclusive license partnership for the commercialization of AVT02, an adalimumab biosimilar, in selected Asia-Pacific markets.
Alvotech, Prestige Biopharma Enter New Manufacturing Partnership contractpharma
August 29, 2019
Alvotech Contract Services to make one of Prestige’s biosimilar candidates.
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets prnasia
August 06, 2019
Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today announced that ...
Alvotech in partnership with Cipla Gulf expresspharma
July 30, 2019
Biopharmaceutical company Alvotech and Cipla Gulf have entered into an exclusive partnership for the commercialisation of AVT02, an adalimumab biosimilar, in select emerging markets.
Alvotech, Cipla Gulf Ink Biosimilar Deal contractpharma
July 30, 2019
Will partner for the commercialization of key biosimilar in select emerging markets.

Previous page 1 2 Next page